Expression of IL-10, TGF-β1 and TNF-α in Cultured Keratinocytes (HaCaT Cells) after IPL Treatment or ALA-IPL Photodynamic Treatment
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Depending on the light dose and concentration of photosensitizer for photodynamic treatment (PDT), a multitude of dose-related events are demonstrable in PDT-treated cells. Sublethal doses may result in the alteration of cytokine release and consequently modify immune actions, rather than cause cell death. Objective: The purpose of this study was to investigate cytokine expression in cultured HaCaT cells after intense pulse light (IPL) treatment or PDT utilizing 5-aminolevulinic acid (ALA) and IPL at sublethal doses. Methods: Cultured HaCaT cells were treated with either IPL only (4, 8 and 12 J/cm2) or ALA-IPL PDT (100μmol/L of ALA; 0, 4, 8, and 12 J/cm2 of IPL). The expression of IL-10, TGF-β1 and TNF-α was investigated by reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assay. Results: IL-10 protein increased up to 5.95-fold after IPL treatment and up to 2.85-fold after PDT. TGF-β1 mRNA and protein showed slight increases after both IPL treatment and PDT, of which the latter induced slightly larger increases. TNF-α mRNA and protein showed no induction or reduction after PDT. Conclusion: Increased expressions of IL-10 and TGF-β1 was observed after PDT. The induction of IL-10 may contribute to the anti-inflammatory effect, which explains the therapeutic benefit of PDT for inflammatory dermatoses, and that of TGF- β1 may be related to the therapeutic effect for psoriasis. The finding that IL-10 induction was more marked after IPL treatment than after PDT suggests that other mechanisms than IL-10 induction in keratinocytes after PDT may participate in the anti-inflammatory effect of PDT.
Abstract
Background: Depending on the light dose and concentration of photosensitizer for photodynamic treatment (PDT), a multitude of dose-related events are demonstrable in PDT-treated cells. Sublethal doses may result in the alteration of cytokine release and consequently modify immune actions, rather than cause cell death. Objective: The purpose of this study was to investigate cytokine expression in cultured HaCaT cells after intense pulse light (IPL) treatment or PDT utilizing 5-aminolevulinic acid (ALA) and IPL at sublethal doses. Methods: Cultured HaCaT cells were treated with either IPL only (4, 8 and 12 J/cm2) or ALA-IPL PDT (100μmol/L of ALA; 0, 4, 8, and 12 J/cm2 of IPL). The expression of IL-10, TGF-β1 and TNF-α was investigated by reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assay. Results: IL-10 protein increased up to 5.95-fold after IPL treatment and up to 2.85-fold after PDT. TGF-β1 mRNA and protein showed slight increases after both IPL treatment and PDT, of which the latter induced slightly larger increases. TNF-α mRNA and protein showed no induction or reduction after PDT. Conclusion: Increased expressions of IL-10 and TGF-β1 was observed after PDT. The induction of IL-10 may contribute to the anti-inflammatory effect, which explains the therapeutic benefit of PDT for inflammatory dermatoses, and that of TGF- β1 may be related to the therapeutic effect for psoriasis. The finding that IL-10 induction was more marked after IPL treatment than after PDT suggests that other mechanisms than IL-10 induction in keratinocytes after PDT may participate in the anti-inflammatory effect of PDT.
참고문헌 (13)
- Babilas P, "Photodynamic therapy in dermatology--an update", Photodermatol Photoimmunol Photomed, 21, pp.142~149 (2005)
- Gold MH, "Acne and PDT: new techniques with lasers and light sources", Lasers Med Sci, 22, pp.67~72 (2007)
- Calzavara-Pinton PG, "Photodynamic therapy: update 2006. Part 1: Photochemistry and photobiology", J Eur Acad Dermatol Venereol, 21, pp.293~302 (2007)
- Gollnick SO, "Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo", Cancer Res, 57, pp.3904~3909 (1997)
- Karrer S, "Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts", Br J Dermatol, 151, pp.776~783 (2004)
- Nyman ES, "Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy", J Photochem Photobiol B, 73, pp.1~28 (2004)
- Hunt DW, "Influence of photodynamic therapy on immunological aspects of disease - an update", Expert Opin Investig Drugs, 9, pp.807~817 (2000)
- Ratkay LG, "Photodynamic therapy in immune (non-oncological) disorders: focus on benzoporphyrin derivatives", Bio Drugs, 14, pp.127~135 (2000)
- Obochi MO, "Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity", Transplantation, 63, pp.810~817 (1997)
- Hunt DW, "Immunomodulatory aspects of photodynamic therapy", Expert Opin Investig Drugs, 7, pp.57~64 (1998)
- Gollnick SO, "IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response", Photochem Photobiol, 74, pp.811~816 (2001)
- Seaton ED, "Investigation of the mechanism of action of nonablative pulsed-dye laser therapy in photorejuvenation and inflammatory acne vulgaris", Br J Dermatol, 155, pp.748~755 (2006)
- Anderson C, "Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression", Photochem Photobiol, 65, pp.895~901 (1997)